Skip to content
Use caution Drug recall · FDA · Published July 21, 2015

Apotex Recalls Verapamil HCl 240mg Due to Dissolution Failure

Apotex recalls one lot of Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg because it failed dissolution specifications. Check your bottle's lot number.

🇺🇸 FDA recall #D1834-2015DrugApotex ›
Take action

Contact the company

Recalling firmApotex Inc.150 Signet Drive · Toronto, Ontario, Canada
✎ GovInfoNow plain-language explainer

Apotex Inc. is recalling one lot of Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg in 500-count bottles. The recall was issued because the product did not meet the first stage dissolution specification limits. This means the medication may not release or work as intended. Read more at govinfonow.com/recall/44004-apotex-inc-recalls-verapamil-hydrochloride-extended-release-tablets-usp-240.

Source Summary by GovInfoNow · govinfonow.com/recall/44004-apotex-inc-recalls-verapamil-hydrochloride-extended-release-tablets-usp-240 · Updated October 12, 2026 · FDA enforcement record: FDA #D1834-2015

Cite this page

“Apotex Recalls Verapamil HCl 240mg Due to Dissolution Failure.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44004-apotex-inc-recalls-verapamil-hydrochloride-extended-release-tablets-usp-240. Based on FDA recall #D1834-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D1834-2015%22&limit=1).

The FDA announced on July 21, 2015, that Apotex Inc. is recalling one lot of Verapamil Hydrochloride Extended-Release tablets due to failed dissolution specifications. The agency classified the recall as Class III.

How to tell if you have it

  • Brand: Apotex
  • Product: Verapamil Hydrochloride Extended-Release Tablets, USP, 240 mg
  • Packaging: 500-count bottles
  • NDC: 60505-2742-5
  • Lot #: KP2621
  • Expiration Date: 8/2015
  • Distribution: Nationwide and Puerto Rico

The hazard

The recall addresses one lot of product that did not meet the first stage dissolution specification limits. The FDA classified the recall as Class III.

Context

GovInfoNow's records show Apotex Inc. has 19 other recalls on record since April 30, 2012. Other recent recalls of similar products include Apotex Metformin Tablets Recall (May 27, 2020), Apotex Atorvastatin 40mg Tablets Recall (Oct. 22, 2019), and Apot: Rite Aid Maximum Strength Ranitidine Tablets Recall (Sept. 24, 2019). Other recent recalls of similar products include Apotex Recalls Paroxetine 37.5mg Due to Dissolution Failure (Sept. 23, 2026), Apotex Paxil CR 37.5mg Tablets Recall (Aug. 13, 2026), and Teva Metoprolol Succinate Extended-Release Tablets Recall (Jan. 29, 2026).

How to tell if you have this one

Look for Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg in 500-count bottles. The product is Rx Only and manufactured by Apotex Research Private Limited in India for Apotex Corp. in Weston, FL. Check the bottle for NDC 60505-2742-5 and Lot # KP2621 with an expiration date of 8/2015.

  • Brand
    Apotex
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Medication

    Verify if your bottle matches the recalled NDC 60505-2742-5 and Lot # KP2621.

  2. Contact Your Pharmacist

    Speak with your pharmacist or healthcare provider to determine if you have the recalled product and what steps to take next.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 19 months after the firm started it.

1. Firm started the recall: Jul 21, 201512. FDA classified it Class III: Sep 30, 201523. Published in FDA’s Enforcement Report: Oct 7, 201534. FDA terminated the recall: Feb 15, 2017420152017
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Where was this product distributed?

The product was distributed nationwide and in Puerto Rico.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D1834-2015 (July 21, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D1834-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA